Suppr超能文献

[危重症强化治疗中的分子输血方法]

[Methods of Molecular Transfusion in the Intensive Therapy of Critical States].

作者信息

Yaroustovsky M B, Abramyan M V, Krotenko N P, Komardina E V

出版信息

Vestn Ross Akad Med Nauk. 2016;71(4):281-7. doi: 10.15690/vramn680.

Abstract

Development of extracorporeal blood purification acquires greater significance in the intensive care of multiple organ failures (MOF) with all the pathophysiological aspects of its constituent parts. MOF are the main cause of mortality among critically ill patients and treatment of these patients require significant investment. The purpose of the implementation of extracorporeal blood correction techniques today is multiple organ support therapy (MOST). Early extracorporeal therapy is used only in the treatment of renal failure. Today extracorporeal techniques are increasingly being used to replace the functions of various organs and systems. MOST includes diffusion, convection, filtration, sorption, apheresis methodic. They affect the molecular and electrolyte composition of blood, allow to correct, repair, replace, and maintain homeostasis in severe multiorgan dysfunction. Extracorporeal new molecular technologies have been successfully applied in the intensive care of severe heart and respiratory failure, acute kidney injury and acute hepatic dysfunction, in the treatment of severe sepsis, metabolic disorders, the correction of immune imbalance.

摘要

体外血液净化技术的发展在多器官功能衰竭(MOF)的重症监护中具有更重要的意义,这涉及到其组成部分的所有病理生理方面。MOF是重症患者死亡的主要原因,对这些患者的治疗需要大量投入。如今实施体外血液净化技术的目的是多器官支持治疗(MOST)。早期的体外治疗仅用于治疗肾衰竭。如今,体外技术越来越多地被用于替代各种器官和系统的功能。MOST包括扩散、对流、过滤、吸附、单采技术。它们影响血液的分子和电解质组成,能够在严重的多器官功能障碍中纠正、修复、替代并维持体内平衡。体外新分子技术已成功应用于重症心脏和呼吸衰竭、急性肾损伤和急性肝功能障碍的重症监护,用于治疗严重脓毒症、代谢紊乱以及纠正免疫失衡。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验